Search results
Compounding pharmacies are making their own versions of blockbuster weight loss drugs
KTEP 88.5 El Paso· 5 days agoAs more people turn to blockbuster drugs like Wegovy to lose weight, some are choosing to skip the name-brand drugs and go online for less expensive alternatives made by specialized ...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly (LLY), Novo Nordisk (NVO), Vertex Pharmaceuticals (VRTX), Intuitive Surgical (ISRG) and...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
CNBC Daily Open: Dow drops on weak manufacturing data, GameStop soars
CNBC· 1 day agoTraders work as a screen displays the trading information for GameStop and AMC Theatres on the floor...
Why Caroline Stanbury Used Ozempic During "Midlife Crisis" Weight Gain
E! News via Yahoo News· 6 days agoReal Housewives of Dubai's Caroline Stanbury opened up about using Ozempic to lose weight, sharing,...
How Ozempic and GLP-1s Are Changing the Business of Travel
Skift· 4 days agoA growing number of consumers are turning to a class of drugs known as GLP-1’s, including Ozempic,...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters· 1 day ago, opens new tab said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations and sending ...
Inside Klarna’s Marketing ‘AI Factory,’ Which Could Save $10M In 2024
Forbes· 7 days agoSweden-based global payments company Klarna has had the goal of bringing generative AI to all of its...
This prescription gummy was designed to treat erectile dysfunction
Fast Company Magazine· 14 hours agoForget popping Viagra or Cialis in plain old pill form. In 2024, erectile dysfunction patients have...
Structure's obesity pill surpasses expectations in mid-stage study
AOL· 2 days agoThe California-based drug developer is vying for a share of the global obesity treatment market that is estimated to be worth about $150 billion by the early 2030s. The current market leaders ...